Fig. 3From: Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)Subgroup analyses for primary endpoint. BMI: body mass index; CI: confidence interval; eGFR: estimated glomerular filtration rate; SUA: serum uric acidBack to article page